The Government of Tanzania has committed TSh 298 billion (equivalent to USD 114 million) over two fiscal years 2024/25 and 2025/26 to strengthen the country’s response to tuberculosis (TB), HIV/AIDS, and malaria amid declining donor support.
The announcement was made by the Chief Medical Officer, Dr Grace Magembe, on July 21, 2025, in Dodoma during a high-level review meeting of the Global Fund budget.
The session convened key stakeholders to align resource allocation with national health priorities and community needs.
Dr Magembe explained that the government is stepping in to fill the funding gap following reduced financial contributions from several development partners.
"Recently, some donor countries scaled down their funding for TB, HIV, and malaria programmes. In response, the government swiftly allocated USD 54 million (TSh 140 billion) for the 2024/25 financial year to sustain the procurement of essential medicines and medical supplies," she said.
She added that the government has increased the allocation to USD 60 million (TSh 159 billion) in the 2025/26 financial year, with a specific focus on reaching underserved communities.
“This additional investment is a clear demonstration of our commitment to ensuring that Tanzanians—especially those most affected—continue to receive quality and accessible healthcare services,” Dr Magembe said.
The Global Fund budget review brought together representatives from the Prime Minister’s Office, the Ministry of Health, the Ministry of Finance, the President’s Office – Regional Administration and Local Government (PO-RALG), the U.S. Embassy, the World Health Organization (WHO), Tanzania’s National Coordinating Mechanism (TNCM), and the Local Fund Agent (LFA).
The meeting aimed to strengthen coordination and accountability among partners while ensuring that health resources are effectively deployed to improve outcomes for millions of Tanzanians.
Tanzania has made notable progress in combating TB, HIV, and malaria over the past decade. However, health officials warn that sustained investments and strong partnerships are essential to maintain gains, close treatment gaps, and achieve universal health coverage targets.